Phage International, Inc.
San Ramon, CA USA Scientific journals, white papers, and other extensive information about bacteriophage therapy. JCP Biochimpharm
Tbilisi, Georgia Beginning in the 1940's G.Eliava Institute of Bacteriophage, Microbiology and Virology produced several types of bacteriophage-based treatments. In 1994 the production group at this Institute separated from the Eliava Institute and formed a new commercial company, JSC Biochimpharm. JSC proceeded to restore mass production of several classic phage preparations, rennovating the bacterial strain and phage collections, and enhanced these products to address newly emerging antibiotic resistant strains. Despite a recent history grave economic and political conditions, Biochimpharm now mass produces of two highly effective polyvalent bacteriophage preparations and several monophage preparations. Biochimpharm's manufacturing capabilities are the world's best in terms of quality, consistency and capacity. Camelyn USA, Inc.
San Ramon, CA USA Phage Therapy Center recommends Kolhketi Honey for all patients -- past, present and future -- to help build and maintain a healthy immune system. Kolkheti Honey is a unique extract of a special honey from the region of Georgia that the ancient people called Kolchis. All of the water, sugar and protein have been removed, leaving only the active ingredients of the honey: peptides, amino acids, antioxidants and minerals. Ludwik Hirszfeld Institute of Immunology and Experimental Therapy
Polish Academy of Science - Wroclaw, Poland Recent human clinical studies performed at Herzfeld Institute, Polish Academy of Sciences Evergreen State College
Olympia, Washington, USA
Phage therapy was first developed early in this century and showed much promise but also aroused much controversy. It has been little used in the West since the advent of antibiotics in the 1940s. However, extensive clinical research and implementation of phage therapy continued to be carried out in Eastern Europe over the last 50 years. The results of that work effectively complement the limited recent animal work in the West that is primarily cited in the recent articles, encouraging optimism that phage can indeed play an important role in dealing with infections involving increasingly drug-resistant microbes. G. Eliava Institute of Bacteriophages, Microbiology and Virology
Georgian Academy of Sciences, Tbilisi, Republic of Georgia, In its heyday in the 1970s and 80s, nearly 800 people worked in the Industrial Branch of the Eliava Institute, using enormous vats, pill stampers and automatic bottling machines to pump out tons of phage products for military and civilian uses all over the Soviet Union. Another 200 worked to analyze hundreds of thousands of bacterial samples that continuously poured in at the direction of the Soviet Ministry of Health, testing the phage cocktails for efficacy and constantly isolating new phage and making refinements. They also fought infectious disease in other ways - vaccines, immune enhancers, probiotic bacterial cultures - but phage were their main focus. By then, Institutes and factories in places like Gorki and Ufa were also producing these phage products for Soviet use, but Tbilisi phage were especially prized as far away as Lithuania even in 1990. |
